• ´Ù¹ß¼º °ñ¼öÁ¾ ȯÀÚ¿¡¼­ ¹ß»ýÇÑ ºñÈ£ÁöŲ¾¾ ¸²ÇÁÁ¾ 1¿¹

• A Case of Multiple Myeloma with Non-Hodgkin's Lymphoma

• ÀåÈ«¹®

• ±è¿ø¼®/¼ÕÀÎ/±èö¿ì/Çã´ë¼®/¹æ¿µÁÖ/¹Ú¼±¾ç/±èº´±¹/±è³ë°æ

• ´ëÇѾÏÇÐȸÁö   1994³â  26±Ç  5È£  847 ~ 852

• Hodgkin¾¾ º´ ȯÀÚ¿¡¼­ °ú·®ÀÇ Vinblastine Åõ¿©ÈÄ ¹ß»ýÇÑ µ¶¼º

• Serious Toxicities Induced by Vinblastine Overdose in a Patient with Relapsed Hodgkin's Disease

• ÇÑ»ó±¹

• ±è¿ëÁÖ/ÇÑÁö¿¬/°­ÁøÇü/¹®ÇѸ²/È«¿µ¼±/±èÈƱ³/ÀÌ°æ½Ä/±èµ¿Áý

• ´ëÇѾÏÇÐȸÁö   1994³â  26±Ç  5È£  841 ~ 846

• ¾×¿Í ÀÓÆÄÀý·Î ¹ßÇöµÈ ÀáÀ缺 À¯¹æ¾Ï

• Occult Breast Cancer Presenting as an Axillary Lymph Node

• ±è¼º¿ë

• Á¶¿ë¿í, Çã°æ¹ß, Çã°æ¹ß

• ´ëÇѾÏÇÐȸÁö   1994³â  26±Ç  5È£  833 ~ 840

• À¯¹æ¾Ï°ú µ¿¹ÝµÈ ÇǺαٿ° 1¿¹

• A Case of Dermatomyositis Accompanying Breast Cancer

• ±Ç¿µÃ¶

• Ȳ±³½Â/Ãß¹«¿±/À±È¯°ï/±è°æÅÂ/ÀüÀç¹Î/±è¹è¿µ/ÃÖ¼º±Ù/¾ÈÈñ±Ç

• ´ëÇѾÏÇÐȸÁö   1994³â  26±Ç  5È£  828 ~ 832

• ¿ø¹ß¼º ¾ÏÁ¾¿¡¼­ÀÇ Acid Stable Trypsin InhibitorÀÇ ¹ßÇö ¹× ºÐÆ÷

• Expression and Distribution of Acid Stable Trypsin Inhibitor in Primary Carcinomas

• ÀÌȲÈñ

• Àå¿øÈñ/±èâÁø/¹Ú¼±¾ç/¹®Çü¹è/À¯¿íÁØ

• ´ëÇѾÏÇÐȸÁö   1994³â  26±Ç  5È£  822 ~ 827

• Á¤»óÀΰú ¾ÏȯÀÚ¿¡¼­ Ç÷Áß Tumor Necrosis Factor-a Ä¡ÀÇ ºñ±³ ¹× Ç×¾ÏÁ¦ Åõ¿©¿¡ µû¸¥ º¯È­

• The Comparison of Blood TNF-a Level between Normal Person and Cancer Patients, and the Change of Blo...

• À̿뱸

• ±è°æ³â

• ´ëÇѾÏÇÐȸÁö   1994³â  26±Ç  5È£  815 ~ 821

• ºñÈ£ÁöŲ ¸²ÇÁÁ¾¿¡ ´ëÇÑ COP-BLAM º¹ÇÕÈ­Çпä¹ýÀÇ Ä¡·áÈ¿°ú

• COP-BLAM Combination Chemotherapy for the Treatment of Intermediated and High Grade Non-Hodgkin's Ly...

• ÀÌÀ缺

• ¼­Àå¼ö, Çö¸í¼ö

• ´ëÇѾÏÇÐȸÁö   1994³â  26±Ç  5È£  806 ~ 814

• À½°æ¾Ï¿¡¼­ Çظéü ħÀ±¿©ºÎ¿¡ ÀÇÇÑ ÀÓÆÄÀý ÀýÁ¦¼úÀÇ ½ÃÇà°áÁ¤

• Determination of Lymphadenectomy in Primary Penile Carcinoma According to the Corpus Cavernosum Inva...

• À̹é

• È«»óÁØ

• ´ëÇѾÏÇÐȸÁö   1994³â  26±Ç  5È£  801 ~ 805

• Àü¸³¼±ÀÇ ¾ç¼º ¹× ¾Ç¼ºÁ¾¾ç¿¡¼­ p53ÀÇ ¹ßÇö

• Expression of p53 in the Benign and Malignant Tumor of Prostate

• ±è±â±Ç

• ´ëÇѾÏÇÐȸÁö   1994³â  26±Ç  5È£  793 ~ 800

• Àü½Å±â ¼Ò¼¼Æ÷ Æó¾Ï¿¡ ´ëÇÑ EP È­Çпä¹ý°ú EP/CAV ±³´ëÈ­Çпä¹ýÀÇ ºñ±³ ¿¬±¸

• A Randomized Comparison of EP Sequential Chemotherapy Verus EP/CAV Alternating Chemotherapy for Exte...

• ¼­Ã¢ÀΠ( Suh Chang-In )

• ¹Ú¿µ¼® ( Park Young-Suk ), Á¤±â¼® ( Chung Ki-Suck ), Çã´ë¼® ( Heo Dae-Seok ), ¹æ¿µÁÖ ( Bang Young-Jue ),&...

• ´ëÇѾÏÇÐȸÁö   1994³â  26±Ç  5È£  786 ~ 792

• ´ÙºÐÇÒ ¹æ»ç¼±Ä¡·á¿¡ ÀÇÇÑ 3±â ºñ¼Ò¼¼Æ÷¼º Æó¾ÏÀÇ Ä¡·á

• Concomitant Boost Radiotherapy in Clinical Stage III Non-Small Cell Lung Cancer

• ¹ÚÂùÀÏ

• ½Å°æȯ

• ´ëÇѾÏÇÐȸÁö   1994³â  26±Ç  5È£  778 ~ 785

• Æó¾Ï Á¶Á÷¿¡¼­ÀÇ Ç÷¾× µ¿Á¾ Ç׿ø AÀÇ Ç¥Çö

• Expressions of Blood Group Antigen A in Lung Cancer

• ÇÑÇ¥¼º

• È«¼®Ã¶/ÀÌÁ¾Áø/Á¶ÇØÁ¤/±è¾Ö°æ/±èÁÖ¿Á/±è¼±¿µ

• ´ëÇѾÏÇÐȸÁö   1994³â  26±Ç  5È£  770 ~ 777

• À¯¹æ¾Ï¿¡¼­ÀÇ p53 ¹ßÇö -¿ø¹ßº´¼Ò¿Í ÀüÀ̺´¼ÒÀÇ ºñ±³-

• p53 Expression in Breast Cancer -Comparison between primary and metastatic lesions-

• Ȳż÷

• ±è¿µ¹è/ÁÖ¿µÃ¤/±èÁعÌ/Á¶°æÀÚ/ÀåÀÚÁØ

• ´ëÇѾÏÇÐȸÁö   1994³â  26±Ç  5È£  764 ~ 769

• È­¼ººÐ¼®±â¸¦ ÀÌ¿ëÇÑ À¯¹æ¾ÏÀÇ AgNORsÀÇ ¼ö¿Í ¸éÀû ÃøÁ¤

• Quantitation of AgNORs in Breast Lesions Using Image Analysis

• ±è¾Ö¸®

• ±è¿µ½Ä, ±èÀμ±

• ´ëÇѾÏÇÐȸÁö   1994³â  26±Ç  5È£  756 ~ 763

• À¯¾Ï ¿¹ÈÄ ÀÎÀڷμ­ c-34bB-2 OncoproteinÀÇ ÀÇÀÇ

• The Significance of c-erbB-2 Oncoprotein as a Prognostic Factor in Human Breast Cancer

• µ¿Áø±Ù

• °­¿µÃ¶

• ´ëÇѾÏÇÐȸÁö   1994³â  26±Ç  5È£  746 ~ 755

• »óºÎ È£Èí±â-¼ÒÈ­±â°üÀÇ À̽üº Á¾¾ç¿¡¼­ÀÇ p53 À¯ÀüÀÚ µ¹¿¬º¯ÀÌ¿¡ °üÇÑ ¿¬±¸

• p53 Mutations in Metachronous Upper Aerodigestive Tract Cancers

• ¾çÇѱ¤/Michael J. Kelley

• ´ëÇѾÏÇÐȸÁö   1994³â  26±Ç  5È£  735 ~ 745

• Á¶±âÀ§¾ÏÀÇ ¸²ÇÁÀý ÀüÀ̾ç»ó

• Prediction of Lymph Node Metastasis in Early Gastric Cancer

• ±è»óÈÆ

• Á¶¿µ¼ö, ¼ÛÁß¿ø

• ´ëÇѾÏÇÐȸÁö   1994³â  26±Ç  5È£  728 ~ 734

• À§¾Ï¿¡¼­ Estrogen ¼ö¿ëü¿¡ ´ëÇÑ ¿¬±¸

• A Study of Estrogen Receptors in Gastric Cancer

• ¹è¹®¿À

• È«¼ø°ü, ±è¿µÁø

• ´ëÇѾÏÇÐȸÁö   1994³â  26±Ç  5È£  722 ~ 727

• ÁøÇ༺ À§¾ÏÀÇ Á¶Á÷ÇÐÀû ºÐ·ù¿¡ µû¸¥ ÀÓ»óÀû Ư¡°ú ¿¹ÈÄ

• Clinical Analysis and Prognosis According to the Histopathologic Type o fAdvanced Gastric Cancer

• ¹®¼ºÇÏ

• ½ÅÇö¿í/½ÉÁ¤¿ø/¾ÈÇý°æ/Á¤°æ¼®

• ´ëÇѾÏÇÐȸÁö   1994³â  26±Ç  5È£  711 ~ 721

• À§¾ÏÁ¾¿¡¼­ p53 ´Ü¹é °ú¹ßÇö°ú ȯÀÚÀÇ ¿¹ÈÄ¿ÍÀÇ °ü°è¿¡ ´ëÇÑ ¿¬±¸

• Prognostic Significance of p53 Overexpression in Gastric Carcinoma

• ±è¿ìÈ£

• ¼Û»ó¿ë/±èÁ¾Àç/±è¿ëÀÏ/±èÁøº¹

• ´ëÇѾÏÇÐȸÁö   1994³â  26±Ç  5È£  702 ~ 710